Reading view

Breast cancer and endometriosis drug Zoladex is being pulled from Australia. How will women be affected?

The vital medicine, made by AstraZeneca, will not be available from November, possibly leaving thousands of women without treatment

Thousands of women could be left without vital breast cancer and endometriosis medicine when AstraZeneca removes its treatment from the Pharmaceutical Benefits Scheme (PBS) and the private market, experts warn.

Zoladex will no longer be available in Australia from November, as the ABC first reported, but some existing patients will still be able to access it for an additional six months.

Continue reading...

© Photograph: Olena Malik/Getty Images

© Photograph: Olena Malik/Getty Images

© Photograph: Olena Malik/Getty Images

  •  

Over HK$140k raised for late Hong Kong hairstylist Pitt Cheung to be donated to cancer NGO

Pitt Cheung

Funds raised for a Hong Kong hairstylist who died from nasopharyngeal cancer in April will be donated to NGO Cancer Information, as per his wishes.

Pitt Cheung
Pitt Cheung. Photo: gogetfunding.com.

Two rounds of fundraising initiatives for Pitt Cheung raised a total of HK$831,000 for his specialist treatment, leaving a balance of over HK$140,000 after his passing in April.

The fundraiser said that Cheung had exhausted radiotherapy, chemotherapy and immunotherapy treatments at public hospitals, so he switched to a recommended chemotherapy drug called Nab-paclitaxel, costing HK$72,000 per month.

Cheung died peacefully in hospital on April 26. A funeral for the 44-year-old was held on May 9.

A post on Pitt Cheung's fundraising Instagram profile on June 7, 2026.
A post on Pitt Cheung’s fundraising Instagram profile on June 7, 2026. Photo: @crowdfunding_for_pitt, via Instagram.

“After deduct[ing] the expenses for chemotherapy, follow-up appointments, check-ups, the chemo port surgery and hospitalisation, we are left with HK$140,620. Per Pitt’s wishes, we will donate this sum to NGO @cancer_information,” a post on Cheung’s fundraising Instagram account said on Sunday.

“This NGO provided lots of professional support and companionship to Pitt when he was fighting cancer, and we hope the funds can be used to help more people.”

The post thanked the Hong Kong United Oncology Centre, where he was cared for, as well as donors, friends and family who supported his journey.

  •  

Edith Sánchez fights for her severance after 25 years working for Luis Miguel: ‘He told me I was like his mother; thank God I never believed it’

Edith Sánchez, in Mexico City, April 16, 2026.

If photographs could make a sound, the one Edith Sánchez keeps in a small plastic bag would play Luis Miguel’s version of Las Mañanitas. Dated September 16, 1994, the photo shows the Mexican singer hugging her as she looks at the camera. It is the only picture she has left beside the man who was her boss for more than 25 years.

Seguir leyendo

Edith Sánchez shows a photograph next to Luis Miguel at a 1994 celebration.An invitation to a party during Luis Miguel's 1999–2000 tour, featuring the name Edith Sánchez.Edith Sánchez's medical record from the Cancer Institute, dated 2017.
  •  

Longevity researcher Juan Carlos Izpisua presents latest data on aging process: ‘It is a loss of identity at the cellular level’

Scientist Juan Carlos Izpisua at the Royal National Academy of Medicine in Spain.

“If no one asks me, I know what time is. When they ask me, I no longer know,” wrote the philosopher Augustine of Hippo 17 centuries ago. Something very similar happens now with aging: we all understand what it is, but when we ask ourselves why we must age and die, doubts arise. Even the world’s leading experts face the same uncertainty: at best they offer very different answers.

Seguir leyendo

Juan Carlos Izpisua at the Royal Academy of Medicine in Madrid.
  •  

A tumor’s ‘signature’ reveals the key to treatment in precision oncology

A potential response to cancer is written — on a microscopic level — in its very tumor cells. For decades, treatment and prognosis of the disease has been largely determined by the organ, the anatomical location in which the cancerous mass is located. But now, science has placed a spotlight on something more ambitious: learning the tumor’s signature, or rather, the molecular alterations that characterize its malignant cells. The latest meeting of the American Society of Clinical Oncology (ASCO), which took place last weekend in Chicago, has given further impetus to precision oncology and highlighted how cancer biology, those microscopic genetic characteristics that define it, are playing an increasingly important role in determining therapeutic approach, and even predicting prognosis.

Seguir leyendo

© Lukas Kabon (Anadolu Agency / Getty)

A researcher handles samples in a laboratory in the Czech Republic.
  •  

Dermatologist explains benefits of newly approved sunscreen ingredient

For the first time in more than 25 years, the FDA has approved a new active ingredient for over-the-counter sunscreens. It clears the way for manufacturers to begin using bemotrizinol, or BEMT, an ingredient that's been used in Europe and Asia since the 1990s. Amna Nawaz discussed why this change took so long and what people should know about it with dermatologist Dr. Rachel Nazarian.

  •  
❌